Olympus is offering unprecedented trade-in values for older generation duodenoscopes to hasten the market transition to this new duodenoscope. In addition, Olympus is including in each sale a Premium Protection Plan that covers service inspections at every 100 uses or annually, whichever comes first. The plan also includes OEM parts and repair performed by OEM-trained technicians in an FDA-regulated facility, as well as protection for three years covering all maintenance and repair.

Post-market Surveillance
Olympus continues its close collaboration with the U.S. FDA in support of the launch and ongoing support of the TJF-Q190V. Pursuant to the 522 Order from the FDA, Olympus is engaging in new post-market surveillance studies for the TJF-Q190V, including human factors and sampling & culturing. These studies will further the understanding of how Olympus can better prevent the risk of infection, an important part of the company's corporate mission. Olympus is committed to working in partnership with our customers, medical societies, and regulatory authorities to keep patients safe while providing physicians the most advanced tools and technology for accurate and effective diagnosis and treatment.

About Olympus Medical Systems Group
Olympus is a global technology leader, crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Throughout our 100-year history, Olympus has focused on being true to society and making people's lives healthier, safer and more fulfilling.

Our Medical Business works with health care professionals to combine our innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing with their skills to deliver diagnostic, therapeutic and minimally invasive procedures to improve clinical outcomes, reduce overall costs and enhance quality of life for patients.


SOURCE Olympus Medical Systems Group

Back to HCB News

Endoscopy Homepage